| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.4M | +55.0% |
| SG&A Expense | $13.3M | +308.5% |
| Operating Income | -$37.7M | -98.4% |
| Pre-tax Income | -$35.2M | -18.7% |
| Net Income | -$35.2M | -18.7% |
| EPS (Basic) | -$2.62 | +64.2% |
| EPS (Diluted) | -$2.62 | +64.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.9M | +125.2% |
| Current Assets | $292.8M | +126.7% |
| Total Assets | $298.7M | +131.2% |
| Current Liabilities | $5.7M | -0.6% |
| Total Liabilities | $9.6M | +69.0% |
| Stockholders' Equity | $289.1M | +718.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.9M | -121.8% |
| Capital Expenditures | $36K | — |
| Investing Cash Flow | -$36K | — |
| Financing Cash Flow | $196.0M | +44.4% |
| Free Cash Flow | -$35.0M | -122.0% |